VTRS
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Viatris announced Japanese approval of WAKIX (pitolisant), a first-in-class treatment for narcolepsy and excessive daytime sleepiness associated with obstructive sleep apnea syndromeSep 16, 2026
- Viatris receives FDA approval for Gwyn Lo, a once-weekly contraceptive patchJul 29, 2026
- Viatris reported positive topline Phase 3 results for VR-205 in Japanese adults with IgA nephropathyJun 29, 2026
- FDA accepted Viatris' NDA for fast-acting meloxicam to treat moderate-to-severe acute painMay 18, 2026
- FDA accepts Viatris’ supplemental NDA for MR-141 (phentolamine ophthalmic solution 0.75%) for presbyopia treatmentFeb 25, 2026